(Q77466405)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

Charles Hannoun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Peter Horal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Magnus Lindh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

INTERPRED Study Group

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medical Virology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

171-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

5 December 2019

cites work

1 reference

Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B.

21 January 2018

1 reference

Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B

21 January 2018

1 reference

Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment

21 January 2018

1 reference

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter

21 January 2018

1 reference

Long-term mutation rates in the hepatitis B virus genome

21 January 2018

1 reference

T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients

21 January 2018

1 reference

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group

21 January 2018

1 reference

Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B.

21 January 2018

1 reference

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

21 January 2018

1 reference

Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers

21 January 2018

1 reference

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers

21 January 2018

1 reference

Natural history and control of perinatally acquired hepatitis B virus infection

21 January 2018

1 reference

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

21 January 2018

1 reference

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

21 January 2018

1 reference

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

21 January 2018

1 reference

The clinical significance of core promoter and precore mutations during the natural course and interferon therapy in patients with chronic hepatitis B

21 January 2018

1 reference

The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.2127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11782925%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference